Literature DB >> 12815366

Thiopurine methyltransferase polymorphisms in a Brazilian population.

W L Boson1, M A Romano-Silva, H Correa, R P Falcão, P V Teixeira-Vidigal, L De Marco.   

Abstract

Thiopurine methyltransferase (TPMT) catalyses the S-methylation of thiopurine drugs. Low-activity phenotypes are correlated with several mutations in the TPMT gene. Polymorphisms of TPMT have been reported for Caucasians, African-Americans and Asians. Since ethnic differences have been demonstrated worldwide, it remains to be elucidated in Brazil. The Brazilian population is the result of five centuries of interethnic crosses between peoples from almost all continents as well as autochthonous Amerindians, all forming the fifth largest and one of the most heterogeneous populations in the world. The frequency of six allelic variants of the TPMT gene, *2 (G238C) (2.2%), *3A (G460A and A719G) (1.5%), *3B (G460A) (0.2%), *3C (A719G) (1.0%), *5 (0%) and *6 (0%) were determined in Brazilian subjects using polymerase chain reaction (PCR)-RFLP and allele-specific PCR-based assays. This study provides the first analysis of TPMT mutant allele frequency in a sample of the Brazilian population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12815366     DOI: 10.1038/sj.tpj.6500175

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


  14 in total

1.  Genetic analysis of thiopurine methyltransferase polymorphism in the Jordanian population.

Authors:  Nancy Hakooz; Tawfiq Arafat; Debbie Payne; William Ollier; Sudeep Pushpakom; Julie Andrews; William Newman
Journal:  Eur J Clin Pharmacol       Date:  2010-06-03       Impact factor: 2.953

2.  Thiopurine S-methyltransferase (TPMT) activity is better determined by biochemical assay versus genotyping in the Jewish population.

Authors:  Yair Kasirer; Rephael Mevorach; Paul Renbaum; Nurit Algur; Devora Soiferman; Rachel Beeri; Yelana Rachman; Reeval Segel; Dan Turner
Journal:  Dig Dis Sci       Date:  2014-01-04       Impact factor: 3.199

3.  Frequency of TPMT alleles in Indian patients with acute lymphatic leukemia and effect on the dose of 6-mercaptopurine.

Authors:  Salamun Desire; Poonkuzhali Balasubramanian; Ashish Bajel; Biju George; Auro Viswabandya; Vikram Mathews; Alok Srivastava; Mammen Chandy
Journal:  Med Oncol       Date:  2009-10-15       Impact factor: 3.064

4.  Distribution of TPMT risk alleles for thiopurine [correction of thioupurine] toxicity in the Israeli population.

Authors:  Edna Efrati; Lior Adler; Norberto Krivoy; Eli Sprecher
Journal:  Eur J Clin Pharmacol       Date:  2008-12-02       Impact factor: 2.953

5.  Frequency of thiopurine S-methyltransferase mutant alleles in indigenous and admixed Guatemalan patients with acute lymphoblastic leukemia.

Authors:  Claudia Garrido; Veronica Giron Santizo; Petra Müllers; Daphney Rigaud Soriano; Giovana Bendfeldt Avila; Michael Dean; Silvia Jimenez-Morales
Journal:  Med Oncol       Date:  2013-02-03       Impact factor: 3.064

6.  Thiopurine-methyltransferase variants in inflammatory bowel disease: prevalence and toxicity in Brazilian patients.

Authors:  Ana Teresa P Carvalho; Barbara C Esberard; Renata S B Fróes; Davy C M Rapozo; Ana B Grinman; Tatiana A Simão; Juliana C V C Santos; Antonio José V Carneiro; Luis Felipe Ribeiro-Pinto; Heitor S P de Souza
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

7.  Thiopurine S-methyltransferase gene (TMPT) polymorphisms in a Mexican population of healthy individuals and leukemic patients.

Authors:  Lucia Taja-Chayeb; Silvia Vidal-Millán; Olga Gutiérrez; Patricia Ostrosky-Wegman; Alfonso Dueñas-González; Myrna Candelaria
Journal:  Med Oncol       Date:  2007-09-06       Impact factor: 3.064

8.  Pharmacogenomic assessment of Mexican and Peruvian populations.

Authors:  Sharon Marsh; Cristi R King; Derek J Van Booven; Jane Y Revollo; Robert H Gilman; Howard L McLeod
Journal:  Pharmacogenomics       Date:  2015       Impact factor: 2.533

Review 9.  Clinical pharmacology and pharmacogenetics of thiopurines.

Authors:  Srikumar Sahasranaman; Danny Howard; Sandip Roy
Journal:  Eur J Clin Pharmacol       Date:  2008-05-28       Impact factor: 3.064

10.  Prevalence of TPMT and ITPA gene polymorphisms and effect on mercaptopurine dosage in Chilean children with acute lymphoblastic leukemia.

Authors:  Mauricio J Farfan; Carolina Salas; Cristina Canales; Felipe Silva; Milena Villarroel; Katherine Kopp; Juan P Torres; María E Santolaya; Jorge Morales
Journal:  BMC Cancer       Date:  2014-04-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.